N

Nouvelle Clinical Research | Cutler Bay, FL

Research site

(Unclaimed)

Location

10700 Caribbean Boulevard Suite 400, Cutler Bay, Florida, United States of America

Site insights

Top conditions

Top treatments

AD109

Atomoxetine

AP1189

Allopurinol

REGN9933

Apixaban

Tc 99m

REGN7508

Aroxybutynin

Lorundrostat

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

The study is a randomized, double blind, placebo-controlled, dose response, phase II, multicentre trial to evaluate the efficacy and safety of oral A...

Enrolling

Rheumatoid Arthritis (RA)

Drug: AP1189, 70 mg

Drug: AP1189 matching placebo

Assessment of CCM in HF With Higher Ejection Fraction (AIM HIGHer)

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure...

Enrolling

Diastolic Heart Failure

Heart Failure With Preserved Ejection Fraction

Device: OPTIMIZER™ Smart Mini System

Device: Cardiac Contractility Modulation Therapy via OPTIMIZER™ Smart Mini System

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

Locations recently updated

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation (ROXI-ATLAS)

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which m...

Enrolling

Atrial Fibrillation (AF)

Drug: REGN7508

Drug: REGN9933